These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31419872)

  • 1. Personalized Medicine in the Context of Comparative Effectiveness Research.
    Basu A
    Forum Health Econ Policy; 2013 Sep; 16(2):S73-S86. PubMed ID: 31419872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public perceptions of comparative effectiveness research and use of evidence in healthcare decision-making.
    Cornwell D; Hu M; Esposito D
    J Comp Eff Res; 2014 Nov; 3(6):623-34. PubMed ID: 25494569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in action: the role of passive personalization in comparative effectiveness research.
    Basu A; Jena AB; Goldman DP; Philipson TJ; Dubois R
    Health Econ; 2014 Mar; 23(3):359-73. PubMed ID: 24123568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Software Engineering Framework for Reusable Design of Personalized Serious Games for Health: Development Study.
    Carlier S; Naessens V; De Backere F; De Turck F
    JMIR Serious Games; 2023 Mar; 11():e40054. PubMed ID: 36877554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case for a comparative, value-based alternative to the patient-centered outcomes research model for comparative effectiveness research.
    Marko NF; Weil RJ
    Neurosurg Focus; 2012 Jul; 33(1):E8. PubMed ID: 22746240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive IT-systems for big data analysis in medicine.
    Isakova J
    Int J Risk Saf Med; 2015; 27 Suppl 1():S108-9. PubMed ID: 26639685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities in the Economics of Personalized Health Care and Prevention.
    Meltzer DO
    Forum Health Econ Policy; 2013 Sep; 16(2):S13-S22. PubMed ID: 31419870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial Personalization of Medical Treatment Decisions: Adverse Effects and Possible Solutions.
    Weyant C; Brandeau ML
    Med Decis Making; 2022 Jan; 42(1):8-16. PubMed ID: 34027738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning opens new horizons in personalized medicine.
    Papadakis GZ; Karantanas AH; Tsiknakis M; Tsatsakis A; Spandidos DA; Marias K
    Biomed Rep; 2019 Apr; 10(4):215-217. PubMed ID: 30988951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prioritizing Research in an Era of Personalized Medicine: The Potential Value of Unexplained Heterogeneity.
    Heath A; Pechlivanoglou P
    Med Decis Making; 2022 Jul; 42(5):649-660. PubMed ID: 35023403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifelong Personalization
    Spaulding S; Shen J; Park HW; Breazeal C
    Front Robot AI; 2021; 8():683066. PubMed ID: 34164437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalization in biomedical-informatics: Methodological considerations and recommendations.
    Kaptein M
    J Biomed Inform; 2019 Feb; 90():103088. PubMed ID: 30634046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating comparative effectiveness research into Medicaid payment policy: views from medical and pharmacy directors.
    Weissman JS; Westrich K; Hargraves JL; Pearson SD; Dubois R; Emond S; Olufajo OA
    J Comp Eff Res; 2015 Mar; 4(2):79-88. PubMed ID: 25825839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers.
    Schumock GT; Pickard AS
    J Comp Eff Res; 2018 Feb; 7(2):177-180. PubMed ID: 29464965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tall order on a tight timeframe: stakeholder perspectives on comparative effectiveness research using electronic clinical data.
    Holve E; Lopez MH; Scott L; Segal C
    J Comp Eff Res; 2012 Sep; 1(5):441-51. PubMed ID: 24236421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Student and educator experiences of maternal-child simulation-based learning: a systematic review of qualitative evidence protocol.
    MacKinnon K; Marcellus L; Rivers J; Gordon C; Ryan M; Butcher D
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):14-26. PubMed ID: 26447004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.